Gilteritinib Maintenance Reduces Relapse in MRD+ AML ...Middle East

Patients with acute myeloid leukemia and who have minimal residual disease following hematopoietic cell transplantation have a reduced risk of relapse with gilteritinib maintenance therapy. MDedge News

Hence then, the article about gilteritinib maintenance reduces relapse in mrd aml was published today ( Wednesday 21/06/2023 - 09:40 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gilteritinib Maintenance Reduces Relapse in MRD+ AML )

Also on site :

• ‘Harry Potter’ Series Star Paapa Essiedu Says He’s Received Death Threats Over Snape Casting: ‘I’ve Been Told, “Quit or I’ll Murder You”’
• Dozens injured after missile strike in Southern Israel
• Door Cam Catches Healthcare Worker After 7-Hour Shift—Footage Says It All